際際滷

際際滷Share a Scribd company logo
RATIONAL OPTIMISM
IN
RESEARCH & DEVELOPMENT
Dennis Lendrem
RATIONAL OPTIMISM
IN
RESEARCH & DEVELOPMENT
Dennis Lendrem
Lendrem D.W., Senn S.J., Lendrem B.C., Isaacs J.D. (2015),
R&D productivity rides again?, Pharmaceut. Statist., 14, 13, doi: 10.1002/pst.1653
Lendrem D., Senn S.J., Lendrem B.C., and Isaacs J.D. (2015), R&D productivity rides
again?, Pharmaceut. Statist., 14, 13, doi: 10.1002/pst.1653
Years
Cycle Time
= 4 yrs
1
2
3
4
5
6
Cycle Time
= 6 yrs
1
2
3
4
5
6
Before After
Years
Cycle Time
= 4 yrs
1
2
3
4
5
6
Cycle Time
= 6 yrs
1
2
3
4
5
6
Before After
Rational Optimism
 By placing tasks in parallel to reduce cycle time we
inadvertently:
 Increased R&D costs
 Increased late-stage attrition rates
 Increased expected time to market
Rational Optimism
 By placing tasks in parallel to reduce cycle time we
inadvertently:
 Increased R&D costs
 Increased late-stage attrition rates
 Increased expected time to market
Lendrem DW, Lendrem BC Torching the Haystack: Modelling fast-fail strategies in drug
development. Drug Discov Today. 2013 Apr;18(7-8):331-6.
http://dx.doi.org/10.1016/j.drudis.2012.11.011
Lendrem DW, Lendrem BC The Development Speed Paradox: Can increasing development
speed reduce R&D productivity? Drug Discov Today. 2014 Mar;9(3):209-214
http://dx.doi.org/10.1016/j.drudis.2013.09.002
Rational Optimism
Looking for a needle in a haystack?
Torch the haystack.
Rational Optimism
 It is more important to do the right science than to do
the wrong science quickly.
 Build opportunities to kill projects earlier in the
development cycle.
 Focus on tests that prevent projects from entering the
development process.
 Focus on tests that allow elimination of projects early
in the development process.
Rational Optimism
Rational Optimism
 Progression Bias
 terminations are viewed as losses and project teams are loss-
averse
 sunk-costs fallacy  terminating a project risks losing investment
that has already been lost
 marginal cost associated with a decision to continue development
may seem trivial compared to the losses associated with
terminating a potential NTD
 organizational and market incentives to load the pipeline with
promising candidates
 Progression bias leads to continued development even in
the light of strong evidence supporting termination.
Rational Optimism
 Rational Optimism
 Continued pursuit of a line of research in the knowledge that it is
likely to be successful.
Rational Optimism
 Rational Optimism
 Continued pursuit of a line of research in the knowledge that it is
likely to be successful.
 Mindless Optimism
 Continued pursuit of a line of research in the hope that it will be
successful.
R&D Progression Bias and Rational Optimism
Rational Optimism
NTD
p
1-硫 A
硫 B
1-p
留 C
1-留 D
Success
Miss
False
Discovery
Success
Rational Optimism
NTD
p
1-硫 A
硫 B
1-p
留 C
1-留 D
Success
Miss
False
Discovery
Success
Rational Optimism
NTD
p
1-硫 A
硫 B
1-p
留 C
1-留 D
Success
Miss
False
Discovery
Success
Rational Optimism
 Opportunity Costs:
Loss due to false negatives = B
NTD
p
1-硫 A
硫 B
1-p
留 C
1-留 D
Success
Miss
False
Discovery
Success
Rational Optimism
 Opportunity Costs:
Loss due to false negatives = B
Loss due to false positives = C
NTD
p
1-硫 A
硫 B
1-p
留 C
1-留 D
Success
Miss
False
Discovery
Success
Rational Optimism
 Opportunity Costs:
Loss due to false negatives = B
Loss due to false positives = CxA
NTD
p
1-硫 A
硫 B
1-p
留 C
1-留 D
Success
Miss
False
Discovery
Success
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
Cost of False Positives
when 留 = 67%
硫 =10%
mindless
optimism
rational
optimismvs
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
硫 =15%Cost of False Positives
when 留 = 67%
mindless
optimism
rational
optimismvs
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
mindless
optimism
rational
optimism 硫 =20%
Cost of False Positives
when 留 = 67%
vs
Rational Optimism
 So?
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
Cost of False Positives
when 留 = 67%
Cost of False Negatives
when 硫 =10%
mindless
optimism
rational
optimism
vs
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
mindless
optimism
rational
optimism Cost of False Negatives
when 硫 =20%
Cost of False Positives
when 留 = 67%
vs
The false negative rate has to be rather high before it outweighs
the cost of false positives!
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
硫 =20%
Cost of False Positives
when 留 = 67%
mindless
optimism
rational
optimismvs
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
硫 =20%
mindless
optimism
rational
optimismvs
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
硫 =20%
mindless
optimism
rational
optimismvs
Rational Optimism
 So?
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
Cost of False Negatives
when 硫 =20%
Cost of False Positives
when 留 = 67%
mindless
optimism
rational
optimism
vs
Opportunity
Costs
(%)
Probability (%)
20
15
10
5
0
25 -
-
-
-
-
-
0 20 40 60 80 100
I I I I I I
Cost of False Negatives
when 硫 =20%
mindless
optimism
rational
optimism
vs
Early Development Late Development
Rational Optimism
 So?
 We fear false negatives, but the opportunity costs of false positives
are huge.
 Terminating projects frees up R&D resources to pursue other
prospects.
 Thinking about opportunity costs allows project teams to reframe
termination decisions as prospective future gains.
Rational Optimism
Lendrem D.W., Lendrem B.C., Peck R.W., Senn S.J., Day, S., Isaacs J.D. (2015),
Progression Bias and Rational Optimism in Research & Development,
Nat. Rev. Drug Discov., In press
NTD
p
1-硫1
1-硫2
1-硫3
1-硫4
1-硫5
1-硫6
1-硫7
1-硫8
硫8
硫7
硫6
硫5
硫4
硫3
硫2
硫1
1-p
留1
留2
留3
留4
留5
留6
留7
留8
1-留8
1-留7
1-留6
1-留5
1-留4
1-留3
1-留2
1-留1
Rational Optimism
 Richard Peck (Roche)
 Stephen Senn (CRP Sant辿)
 Simon Day (MHRA)
 John Isaacs (MRG)
 John Loughlin (MRG)
NIHR Newcastle BRC
Rational Optimism
 Richard Peck (Roche)
 Stephen Senn (CRP Sant辿)
 Simon Day (MHRA)
 John Isaacs (MRG)
 John Loughlin (MRG)
 Clare Lendrem (AHG)
NIHR Newcastle BRC
fin

More Related Content

Similar to R&D Progression Bias and Rational Optimism (20)

PDF
Bringing Science to Software Development
Arty Starr
PPTX
Overconfidence
Devina Chhajer
PDF
Barriers to growth report
DonorVoice
PDF
Discussion week 1
pejansen
PDF
How does Optimism impact on Entrepreneurs Overconfidence?
CSCJournals
PDF
BPM2014
Keith Swenson
PPTX
Optimism
Arjun Deswal
PDF
Agile and Antifragile
Luc Taesch
PPTX
Improving Performance in Operations
GovLoop
PPT
Introduction to Project Decision Analysis
Intaver Insititute
PDF
Entrepreneurial Psychology
jericsinger
PPTX
Data-Driven off a Cliff: Anti-Patterns in Evidence-Based Decision Making
indeedeng
PPTX
Decision Making for the Project Leader
razausman
PPT
Ch 5- Perception and Individual Decision-making.ppt
ProfMaseeraPatel
PDF
Why You're a Terrible PM: Cognitive Biases in Project Management notes
Carson Pierce
PPTX
PDM
pavitradhamija1
PDF
M Organizational Behavior 2nd Edition McShane Solutions Manual
mlesraxue9171
PDF
M Organizational Behavior 2nd Edition McShane Solutions Manual
uneefpof447
PDF
M Organizational Behavior 2nd Edition McShane Solutions Manual
karydaloark
PDF
Busting the myths of decision making
The BrainLink Group
Bringing Science to Software Development
Arty Starr
Overconfidence
Devina Chhajer
Barriers to growth report
DonorVoice
Discussion week 1
pejansen
How does Optimism impact on Entrepreneurs Overconfidence?
CSCJournals
BPM2014
Keith Swenson
Optimism
Arjun Deswal
Agile and Antifragile
Luc Taesch
Improving Performance in Operations
GovLoop
Introduction to Project Decision Analysis
Intaver Insititute
Entrepreneurial Psychology
jericsinger
Data-Driven off a Cliff: Anti-Patterns in Evidence-Based Decision Making
indeedeng
Decision Making for the Project Leader
razausman
Ch 5- Perception and Individual Decision-making.ppt
ProfMaseeraPatel
Why You're a Terrible PM: Cognitive Biases in Project Management notes
Carson Pierce
M Organizational Behavior 2nd Edition McShane Solutions Manual
mlesraxue9171
M Organizational Behavior 2nd Edition McShane Solutions Manual
uneefpof447
M Organizational Behavior 2nd Edition McShane Solutions Manual
karydaloark
Busting the myths of decision making
The BrainLink Group

Recently uploaded (20)

PPTX
Yoga Postures to Practice for Holistic (Physical, Mental, and Cognitive) Well...
Bhoj Raj Singh
PDF
First Stage of ED Therapy Best Sexologist in Patna Bihar Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
PPT
Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy ...
PVI, PeerView Institute for Medical Education
PPTX
Global Harmonization Task Force (GHTF) and International Medical Device Regul...
Arpan Das
PPTX
OUR SRS SBRT EXPERIENCE BY DR KANHU CHARAN PATRO
Kanhu Charan
PPTX
VSWarehouse 3: Secondary Analysis Platform Overview
Golden Helix
PPT
clinical approach to a woman with gynecological problem.ppt
Faculty of Medicine
PPTX
HEAVY METAL POISONING AND CHELATING AGENTS
MonicaBoggarapu
PDF
Consult Best Sexologist Patna Bihar Chronic ED Treatment Dr Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
PPTX
Mastering the Review Article: Structure, Strategy & Success
Rajendra Dev Bhatt
PPTX
Use of Artificial Intelligence in the Management of Osteoporosis
DrOmLakhani1
PDF
ANATOMY OF LARYNX -Prof.Dr.N.Mugunthan, KMMC.pdf
Kanyakumari Medical Mission Research Center, Muttom
PPTX
Nutrition part 1 , Dietary Goals , Macronutrients
Dr. Anu Marhatta
PPTX
Tuberculosis burden , case finding tools and management .pptx
Dr. Anu Marhatta
PDF
ANATOMY OF FACIAL NERVE AND IT'S APPLIED ASPECTS - Prof.DrN.Mugunthan KMMC.pdf
Kanyakumari Medical Mission Research Center, Muttom
PPTX
BANDHA (BANDAGES) PPT.pptx in ayurveda details
Mahesh Mane
PDF
Clinical studies & observational trials in the age of AI
Paul Agapow
PPT
Treatment Planning Made CLEAR in Neuroendocrine Tumors & Pancreatic Cancer: P...
PVI, PeerView Institute for Medical Education
PDF
Special Education: Empowering Children Through Therapy and油Support
MyChildTherapy
PDF
2024 ESC GUIDELINES FOR MANAGEMENT OF ELEVATED BLOOD PRESSURE AND HYPERTENSIO...
BOBBIESARFOAKOSUA
Yoga Postures to Practice for Holistic (Physical, Mental, and Cognitive) Well...
Bhoj Raj Singh
First Stage of ED Therapy Best Sexologist in Patna Bihar Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy ...
PVI, PeerView Institute for Medical Education
Global Harmonization Task Force (GHTF) and International Medical Device Regul...
Arpan Das
OUR SRS SBRT EXPERIENCE BY DR KANHU CHARAN PATRO
Kanhu Charan
VSWarehouse 3: Secondary Analysis Platform Overview
Golden Helix
clinical approach to a woman with gynecological problem.ppt
Faculty of Medicine
HEAVY METAL POISONING AND CHELATING AGENTS
MonicaBoggarapu
Consult Best Sexologist Patna Bihar Chronic ED Treatment Dr Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
Mastering the Review Article: Structure, Strategy & Success
Rajendra Dev Bhatt
Use of Artificial Intelligence in the Management of Osteoporosis
DrOmLakhani1
ANATOMY OF LARYNX -Prof.Dr.N.Mugunthan, KMMC.pdf
Kanyakumari Medical Mission Research Center, Muttom
Nutrition part 1 , Dietary Goals , Macronutrients
Dr. Anu Marhatta
Tuberculosis burden , case finding tools and management .pptx
Dr. Anu Marhatta
ANATOMY OF FACIAL NERVE AND IT'S APPLIED ASPECTS - Prof.DrN.Mugunthan KMMC.pdf
Kanyakumari Medical Mission Research Center, Muttom
BANDHA (BANDAGES) PPT.pptx in ayurveda details
Mahesh Mane
Clinical studies & observational trials in the age of AI
Paul Agapow
Treatment Planning Made CLEAR in Neuroendocrine Tumors & Pancreatic Cancer: P...
PVI, PeerView Institute for Medical Education
Special Education: Empowering Children Through Therapy and油Support
MyChildTherapy
2024 ESC GUIDELINES FOR MANAGEMENT OF ELEVATED BLOOD PRESSURE AND HYPERTENSIO...
BOBBIESARFOAKOSUA
Ad

R&D Progression Bias and Rational Optimism

  • 1. RATIONAL OPTIMISM IN RESEARCH & DEVELOPMENT Dennis Lendrem
  • 2. RATIONAL OPTIMISM IN RESEARCH & DEVELOPMENT Dennis Lendrem
  • 3. Lendrem D.W., Senn S.J., Lendrem B.C., Isaacs J.D. (2015), R&D productivity rides again?, Pharmaceut. Statist., 14, 13, doi: 10.1002/pst.1653
  • 4. Lendrem D., Senn S.J., Lendrem B.C., and Isaacs J.D. (2015), R&D productivity rides again?, Pharmaceut. Statist., 14, 13, doi: 10.1002/pst.1653
  • 5. Years Cycle Time = 4 yrs 1 2 3 4 5 6 Cycle Time = 6 yrs 1 2 3 4 5 6 Before After
  • 6. Years Cycle Time = 4 yrs 1 2 3 4 5 6 Cycle Time = 6 yrs 1 2 3 4 5 6 Before After
  • 7. Rational Optimism By placing tasks in parallel to reduce cycle time we inadvertently: Increased R&D costs Increased late-stage attrition rates Increased expected time to market
  • 8. Rational Optimism By placing tasks in parallel to reduce cycle time we inadvertently: Increased R&D costs Increased late-stage attrition rates Increased expected time to market Lendrem DW, Lendrem BC Torching the Haystack: Modelling fast-fail strategies in drug development. Drug Discov Today. 2013 Apr;18(7-8):331-6. http://dx.doi.org/10.1016/j.drudis.2012.11.011 Lendrem DW, Lendrem BC The Development Speed Paradox: Can increasing development speed reduce R&D productivity? Drug Discov Today. 2014 Mar;9(3):209-214 http://dx.doi.org/10.1016/j.drudis.2013.09.002
  • 9. Rational Optimism Looking for a needle in a haystack? Torch the haystack.
  • 10. Rational Optimism It is more important to do the right science than to do the wrong science quickly. Build opportunities to kill projects earlier in the development cycle. Focus on tests that prevent projects from entering the development process. Focus on tests that allow elimination of projects early in the development process.
  • 12. Rational Optimism Progression Bias terminations are viewed as losses and project teams are loss- averse sunk-costs fallacy terminating a project risks losing investment that has already been lost marginal cost associated with a decision to continue development may seem trivial compared to the losses associated with terminating a potential NTD organizational and market incentives to load the pipeline with promising candidates Progression bias leads to continued development even in the light of strong evidence supporting termination.
  • 13. Rational Optimism Rational Optimism Continued pursuit of a line of research in the knowledge that it is likely to be successful.
  • 14. Rational Optimism Rational Optimism Continued pursuit of a line of research in the knowledge that it is likely to be successful. Mindless Optimism Continued pursuit of a line of research in the hope that it will be successful.
  • 16. Rational Optimism NTD p 1-硫 A 硫 B 1-p 留 C 1-留 D Success Miss False Discovery Success
  • 17. Rational Optimism NTD p 1-硫 A 硫 B 1-p 留 C 1-留 D Success Miss False Discovery Success
  • 18. Rational Optimism NTD p 1-硫 A 硫 B 1-p 留 C 1-留 D Success Miss False Discovery Success
  • 19. Rational Optimism Opportunity Costs: Loss due to false negatives = B NTD p 1-硫 A 硫 B 1-p 留 C 1-留 D Success Miss False Discovery Success
  • 20. Rational Optimism Opportunity Costs: Loss due to false negatives = B Loss due to false positives = C NTD p 1-硫 A 硫 B 1-p 留 C 1-留 D Success Miss False Discovery Success
  • 21. Rational Optimism Opportunity Costs: Loss due to false negatives = B Loss due to false positives = CxA NTD p 1-硫 A 硫 B 1-p 留 C 1-留 D Success Miss False Discovery Success
  • 22. Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I Cost of False Positives when 留 = 67% 硫 =10% mindless optimism rational optimismvs
  • 23. Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I 硫 =15%Cost of False Positives when 留 = 67% mindless optimism rational optimismvs
  • 24. Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I mindless optimism rational optimism 硫 =20% Cost of False Positives when 留 = 67% vs
  • 25. Rational Optimism So? Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I Cost of False Positives when 留 = 67% Cost of False Negatives when 硫 =10% mindless optimism rational optimism vs Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I mindless optimism rational optimism Cost of False Negatives when 硫 =20% Cost of False Positives when 留 = 67% vs The false negative rate has to be rather high before it outweighs the cost of false positives!
  • 26. Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I 硫 =20% Cost of False Positives when 留 = 67% mindless optimism rational optimismvs
  • 27. Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I 硫 =20% mindless optimism rational optimismvs
  • 28. Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I 硫 =20% mindless optimism rational optimismvs
  • 29. Rational Optimism So? Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I Cost of False Negatives when 硫 =20% Cost of False Positives when 留 = 67% mindless optimism rational optimism vs Opportunity Costs (%) Probability (%) 20 15 10 5 0 25 - - - - - - 0 20 40 60 80 100 I I I I I I Cost of False Negatives when 硫 =20% mindless optimism rational optimism vs Early Development Late Development
  • 30. Rational Optimism So? We fear false negatives, but the opportunity costs of false positives are huge. Terminating projects frees up R&D resources to pursue other prospects. Thinking about opportunity costs allows project teams to reframe termination decisions as prospective future gains.
  • 31. Rational Optimism Lendrem D.W., Lendrem B.C., Peck R.W., Senn S.J., Day, S., Isaacs J.D. (2015), Progression Bias and Rational Optimism in Research & Development, Nat. Rev. Drug Discov., In press NTD p 1-硫1 1-硫2 1-硫3 1-硫4 1-硫5 1-硫6 1-硫7 1-硫8 硫8 硫7 硫6 硫5 硫4 硫3 硫2 硫1 1-p 留1 留2 留3 留4 留5 留6 留7 留8 1-留8 1-留7 1-留6 1-留5 1-留4 1-留3 1-留2 1-留1
  • 32. Rational Optimism Richard Peck (Roche) Stephen Senn (CRP Sant辿) Simon Day (MHRA) John Isaacs (MRG) John Loughlin (MRG) NIHR Newcastle BRC
  • 33. Rational Optimism Richard Peck (Roche) Stephen Senn (CRP Sant辿) Simon Day (MHRA) John Isaacs (MRG) John Loughlin (MRG) Clare Lendrem (AHG) NIHR Newcastle BRC
  • 34. fin

Editor's Notes

  • #8: As a result, the industry became really slick at delivering late-stage failures to the market place, precipitating the current R&D productivity crisis.
  • #9: As a result, the industry became really slick at delivering late-stage failures to the market place, precipitating the current R&D productivity crisis.
  • #11: 10